1766:HKEXToken Corporation Analysis
Data as of 2026-03-12 - not real-time
¥14,270.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Token Corporation (1766.T) is trading at ¥14,270, well below its 20‑day (¥14,807) and 200‑day (¥14,399) simple moving averages, indicating a clear technical discount. The RSI of 31.7 suggests the stock is oversold, while a bearish MACD histogram reinforces short‑term downside pressure. Fundamentally, the company trades at a PE of 11.4, dramatically lower than the industry average of 32.6, and a DCF‑derived fair value of approximately ¥26,144, pointing to substantial undervaluation. With zero debt, a cash pile exceeding ¥132 bn, and a modest payout ratio of 26%, the 2.47% dividend appears sustainable. Return metrics are respectable, with ROE around 12.8% and operating margins near 5.5%, supporting the case for value‑oriented investors. Overall, the blend of a deep valuation gap, strong balance sheet, and attractive yield makes the stock a compelling candidate for a re‑rating.
The volatility over the past 30 days is about 14%, and the computed beta of 0.09 signals very low market sensitivity, which mitigates systematic risk. Increasing volume hints at growing market interest despite the current price pressure. Sector‑specific risks remain moderate given the cyclical nature of Japanese real‑estate services, but regulatory and geographic exposures are limited. Liquidity on the HKEX is modest, warranting attention for larger positions. In sum, the technical oversold condition combined with a fundamentally sound, undervalued profile suggests a potential upside as the market re‑aligns.
The volatility over the past 30 days is about 14%, and the computed beta of 0.09 signals very low market sensitivity, which mitigates systematic risk. Increasing volume hints at growing market interest despite the current price pressure. Sector‑specific risks remain moderate given the cyclical nature of Japanese real‑estate services, but regulatory and geographic exposures are limited. Liquidity on the HKEX is modest, warranting attention for larger positions. In sum, the technical oversold condition combined with a fundamentally sound, undervalued profile suggests a potential upside as the market re‑aligns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support at ¥14,180
- Oversold RSI indicating potential bounce
- Bearish MACD suggesting caution
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value far above market price
- Attractive 2.47% dividend with low payout ratio
- Strong cash position and zero debt
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend and solid ROE
- Low beta and modest volatility reducing systemic risk
- Long‑term upside potential from sector recovery and undervaluation
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin4.49%
P/E Ratio11.4
ROE12.83%
ROA6.44%
P/B Ratio1.4
Op. Cash Flow¥20.1B
Free Cash Flow¥13.2B
Industry P/E32.6
Technical Analysis
TrendNeutral
RSI31.7
Support¥14,180.00
Resistance¥15,450.00
MA 20¥14,807.00
MA 50¥14,871.40
MA 200¥14,398.90
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair Value¥26,143.78
GradeUndervalued
TypeValue
Dividend Yield2.47%
Risk Assessment
Beta0.09
Volatility14.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.